{"transactions":[{"id":9945,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-12T00:07:43.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":556,"price":331.11,"value":184097.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 350 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42256,"source":{"system":"sec-edgar","filing":"0000318154-26-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000091/form4.xml","form_type":"4"}},{"id":10066,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:48:43.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":19002,"price":329.59,"value":6262869.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027, subject to proration based on the number of completed months of active employment in 2026."}],"balance_after":19002,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":19002},"source":{"system":"sec-edgar","filing":"0000318154-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000073/form4.xml","form_type":"4"}},{"id":10065,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-08T00:48:43.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":454,"price":329.59,"value":149633.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42812,"source":{"system":"sec-edgar","filing":"0000318154-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000073/form4.xml","form_type":"4"}},{"id":10064,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-08T00:48:43.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":2912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027, subject to proration based on the number of completed months of active employment in 2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":43266,"source":{"system":"sec-edgar","filing":"0000318154-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000073/form4.xml","form_type":"4"}},{"id":10279,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-06T00:12:54.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":687,"price":329.82,"value":226586.34,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 442 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":40354,"source":{"system":"sec-edgar","filing":"0000318154-26-000067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000067/form4.xml","form_type":"4"}},{"id":10278,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-06T00:12:54.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":746,"price":329.82,"value":246045.72,"ownership":{"direct":true},"balance_after":41041,"source":{"system":"sec-edgar","filing":"0000318154-26-000067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000067/form4.xml","form_type":"4"}},{"id":11781,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-19T00:38:38.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":6022,"price":366.21,"value":2205316.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 744 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":41787,"source":{"system":"sec-edgar","filing":"0000318154-26-000032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000032/form4.xml","form_type":"4"}},{"id":12098,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-06T01:42:19.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":12063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 667 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":47650,"source":{"system":"sec-edgar","filing":"0000318154-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000021/form4.xml","form_type":"4"}},{"id":17356,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-11-13T00:42:37.000Z","date":"2025-11-12","kind":"gift","planned":false,"acquired":false,"shares":309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported involved a gift by the reporting person of shares of the Company's common stock to a non-profit charitable organization."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 583 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":35503,"source":{"system":"sec-edgar","filing":"0000318154-25-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000080/form4.xml","form_type":"4"}},{"id":17355,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-11-13T00:42:37.000Z","date":"2025-11-11","kind":"gift","planned":false,"acquired":false,"shares":6490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported involved a gift by the reporting person of shares of the Company's common stock to a charitable donor advised fund."}],"balance_after":35812,"source":{"system":"sec-edgar","filing":"0000318154-25-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000080/form4.xml","form_type":"4"}},{"id":24222,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Nqso (Right to Buy)","published_at":"2025-05-09T00:59:57.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":22944,"price":270.44,"value":6204975.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026."}],"balance_after":22944,"derivative":{"exercise_price":270.44,"exercise_date":"2026-05-06","expiration_date":"2035-05-06","underlying":"Common Stock","underlying_shares":22944},"source":{"system":"sec-edgar","filing":"0001127602-25-013786","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013786/form4.xml","form_type":"4"}},{"id":24221,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-05-09T00:59:57.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":3549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 397 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42116,"source":{"system":"sec-edgar","filing":"0001127602-25-013786","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013786/form4.xml","form_type":"4"}},{"id":24362,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-05-07T00:15:55.000Z","date":"2025-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":665,"price":283.78,"value":188713.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 397 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":38567,"source":{"system":"sec-edgar","filing":"0001127602-25-013533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013533/form4.xml","form_type":"4"}},{"id":24361,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-05-07T00:15:55.000Z","date":"2025-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":702,"price":283.78,"value":199213.56,"ownership":{"direct":true},"balance_after":39232,"source":{"system":"sec-edgar","filing":"0001127602-25-013533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013533/form4.xml","form_type":"4"}},{"id":24462,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-05-03T01:31:31.000Z","date":"2025-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":768,"price":288.56,"value":221614.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 607 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":39934,"source":{"system":"sec-edgar","filing":"0001127602-25-013286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013286/form4.xml","form_type":"4"}},{"id":25597,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-20T00:22:11.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3635,"price":313.71,"value":1140335.85,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 792 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":40702,"source":{"system":"sec-edgar","filing":"0001127602-25-010060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225010060/form4.xml","form_type":"4"}},{"id":25972,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-06T01:08:58.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":7277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 707 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":44199,"source":{"system":"sec-edgar","filing":"0001127602-25-008428","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225008428/form4.xml","form_type":"4"}},{"id":27261,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Nqso (Right to Buy)","published_at":"2025-02-22T01:06:00.000Z","date":"2025-02-19","kind":"exercise","planned":false,"acquired":false,"shares":8711,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":156.35,"exercise_date":"2018-05-03","expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":8711},"source":{"system":"sec-edgar","filing":"0001127602-25-006282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225006282/form4.xml","form_type":"4"}},{"id":27260,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-02-22T01:06:00.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":25225,"price":304.441,"value":7679524.225,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is an average price. The prices ranged from $297.19 to $305.33 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These shares include 707 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":36922,"source":{"system":"sec-edgar","filing":"0001127602-25-006282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225006282/form4.xml","form_type":"4"}},{"id":27259,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-02-22T01:06:00.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":8711,"price":293.2182,"value":2554223.7402,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is an average price. The prices ranged from $291.90 to $295.97 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer."}],"balance_after":62147,"source":{"system":"sec-edgar","filing":"0001127602-25-006282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225006282/form4.xml","form_type":"4"}},{"id":27258,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-02-22T01:06:00.000Z","date":"2025-02-19","kind":"exercise","planned":false,"acquired":true,"shares":8711,"price":156.35,"value":1361964.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired in connection with the exercise of stock options expiring on May 3, 2026."}],"balance_after":70858,"source":{"system":"sec-edgar","filing":"0001127602-25-006282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225006282/form4.xml","form_type":"4"}},{"id":41066,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Nqso (Right to Buy)","published_at":"2024-05-09T23:07:58.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":20767,"price":300.3,"value":6236330.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively."}],"balance_after":20767,"derivative":{"exercise_price":300.3,"exercise_date":"2026-05-07","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":20767},"source":{"system":"sec-edgar","filing":"0001127602-24-014858","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014858/form4.xml","form_type":"4"}},{"id":41065,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-05-09T23:07:58.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":3196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,363 RSUs which will vest on 4/30/2025; 2,611 RSUs which will vest in installments of 1,286 on 5/2/2025, 1,325 on 5/2/2026; 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027; and 3,196 RSUs which will vest in installments of 1,054 on 5/7/2026, 1,055 on 5/7/2027, and 1,087 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 449 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":61889,"source":{"system":"sec-edgar","filing":"0001127602-24-014858","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014858/form4.xml","form_type":"4"}},{"id":41210,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-05-08T00:37:43.000Z","date":"2024-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":633,"price":311.29,"value":197046.57,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,363 RSUs which will vest on 4/30/2025; 2,611 RSUs which will vest in installments of 1,286 on 5/2/2025, and 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 449 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":58693,"source":{"system":"sec-edgar","filing":"0001127602-24-014512","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014512/form4.xml","form_type":"4"}},{"id":41384,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-05-03T23:24:17.000Z","date":"2024-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":650,"price":277.37,"value":180290.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 1,363 RSUs which will vest on 4/30/2025; 2,611 RSUs which will vest in installments of 1,286 on 5/2/2025, and 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 607 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":59326,"source":{"system":"sec-edgar","filing":"0001127602-24-014196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014196/form4.xml","form_type":"4"}},{"id":41589,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-05-01T23:54:56.000Z","date":"2024-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":690,"price":276.38,"value":190702.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 1,363 RSUs which will vest on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 each on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 694 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":59976,"source":{"system":"sec-edgar","filing":"0001127602-24-013813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224013813/form4.xml","form_type":"4"}},{"id":42708,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-21T00:11:28.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":6202,"price":268.87,"value":1667531.74,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 2,685 RSUs which will vest in installments of 1,322 on 4/30/2024 and 1,363 on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 each on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 829 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":60666,"source":{"system":"sec-edgar","filing":"0001127602-24-010858","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224010858/form4.xml","form_type":"4"}},{"id":43694,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-08T22:32:46.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":12407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 2,685 RSUs which will vest in installments of 1,322 on 4/30/2024 and 1,363 on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 each on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 715 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":66653,"source":{"system":"sec-edgar","filing":"0001127602-24-009247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224009247/form4.xml","form_type":"4"}},{"id":50365,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2023-11-30T01:44:24.000Z","date":"2023-11-28","kind":"gift","planned":false,"acquired":false,"shares":165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported involved gifts by the reporting person of shares of the Company's common stock to six charitable organizations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 2,685 RSUs which will vest in installments of 1,322 on 4/30/2024 and 1,363 on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 each on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 633 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":54164,"source":{"system":"sec-edgar","filing":"0001127602-23-028437","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223028437/form4.xml","form_type":"4"}},{"id":56096,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2023-05-09T23:24:21.000Z","date":"2023-05-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":594,"price":231.89,"value":137742.66,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 2,685 RSUs which will vest in installments of 1,322 on 4/30/2024 and 1,363 on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 418 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":54114,"source":{"system":"sec-edgar","filing":"0001127602-23-015051","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223015051/form4.xml","form_type":"4"}},{"id":56265,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2023-05-05T00:32:24.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":32250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively."}],"balance_after":32250,"derivative":{"exercise_price":235.97,"exercise_date":"2025-05-02","expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":32250},"source":{"system":"sec-edgar","filing":"0001127602-23-014612","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014612/form4.xml","form_type":"4"}},{"id":56264,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2023-05-05T00:32:24.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":819,"price":235.97,"value":193259.43,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 2,325 RSUs which will vest in installments of 1,145 on 5/5/2023 and 1,180 on 5/5/2024; 2,685 RSUs which will vest in installments of 1,322 on 4/30/2024 and 1,363 on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 528 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":54708,"source":{"system":"sec-edgar","filing":"0001127602-23-014612","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014612/form4.xml","form_type":"4"}},{"id":56263,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2023-05-05T00:32:24.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":3814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively."}],"balance_after":55527,"source":{"system":"sec-edgar","filing":"0001127602-23-014612","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014612/form4.xml","form_type":"4"}},{"id":56439,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2023-05-03T00:28:23.000Z","date":"2023-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":666,"price":239.74,"value":159666.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,534 RSUs which will vest on 5/3/2023; 2,325 RSUs which vest in installments of 1,145 on 5/5/2023 and 1,180 on 5/5/2024; 2,685 RSUs which vest in installments of 1,322 on 4/30/2024 and 1,363 on 4/30/2025; and 3,897 RSUs which will vest in two installments of 1,286 on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 725 DEs granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":51713,"source":{"system":"sec-edgar","filing":"0001127602-23-014157","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014157/form4.xml","form_type":"4"}},{"id":57233,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2023-03-20T23:14:56.000Z","date":"2023-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3978,"price":234.57,"value":933119.46,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 1,534 RSUs which will vest on 5/3/2023; 2,325 RSUs which vest in installments of 1,145 on 5/5/2023 and 1,180 on 5/5/2024; 4,006 RSUs which vest in installments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025; and 3,897 RSUs which will vest in two installments of 1,286 on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 811 DEs granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":52379,"source":{"system":"sec-edgar","filing":"0001127602-23-010922","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223010922/form4.xml","form_type":"4"}},{"id":57605,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2023-03-09T00:04:42.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":7947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 1,534 RSUs which will vest on 5/3/2023; 2,325 RSUs which vest in installments of 1,145 on 5/5/2023 and 1,180 on 5/5/2024; 4,006 RSUs which vest in installments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025; and 3,897 RSUs which will vest in two installments of 1,286 on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 695 DEs granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":56167,"source":{"system":"sec-edgar","filing":"0001127602-23-009495","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223009495/form4.xml","form_type":"4"}},{"id":61981,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2022-11-04T01:38:31.000Z","date":"2022-11-02","kind":"tax_withholding","acquired":false,"shares":2440,"price":272.06,"value":663826.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2,440 shares issuable upon the vesting of Restricted Stock Units (RSUs) and related Dividend Equivalents (DEs) on 11/2/2022 were withheld by the Company to cover related tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 1,534 RSUs which will vest on 5/3/2023; 2,325 RSUs which vest in installments of 1,145 on 5/5/2023 and 1,180 on 5/5/2024; 4,006 RSUs which vest in installments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025; and 3,897 RSUs which will vest in two installments of 1,286 on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 611 DEs granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":48136,"source":{"system":"sec-edgar","filing":"0001127602-22-024930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222024930/form4.xml","form_type":"4"}},{"id":66492,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2022-05-09T23:12:36.000Z","date":"2022-05-05","kind":"tax_withholding","acquired":false,"shares":575,"price":236.1,"value":135757.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,363 RSUs which will vest on 11/2/2022; 1,534 RSUs which will vest on 5/3/2023; 2,325 RSUs which vest in installments of 1,145 on 5/5/2023 and 1,180 on 5/5/2024; 4,006 RSUs which vest in installments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025; and 3,897 RSUs which will vest in two installments of 1,286 on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 897 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":50307,"source":{"system":"sec-edgar","filing":"0001127602-22-013876","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013876/form4.xml","form_type":"4"}},{"id":66644,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2022-05-05T00:07:51.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":31817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively."}],"balance_after":31817,"derivative":{"exercise_price":230.92,"exercise_date":"2024-05-02","expiration_date":"2032-05-02","underlying":"Common Stock","underlying_shares":31817},"source":{"system":"sec-edgar","filing":"0001127602-22-013352","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013352/form4.xml","form_type":"4"}},{"id":66643,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2022-05-05T00:07:51.000Z","date":"2022-05-03","kind":"tax_withholding","acquired":false,"shares":770,"price":230.92,"value":177808.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 4,363 RSUs which will vest on 11/2/2022; 1,534 RSUs which will vest on 5/3/2023; 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024; 4,006 RSUs which vest in installments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025; and 3,897 RSUs which will vest in two installments of 1,286 on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 967 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":50882,"source":{"system":"sec-edgar","filing":"0001127602-22-013352","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013352/form4.xml","form_type":"4"}},{"id":66642,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2022-05-05T00:07:51.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":3897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively."}],"balance_after":51652,"source":{"system":"sec-edgar","filing":"0001127602-22-013352","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013352/form4.xml","form_type":"4"}},{"id":66874,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2022-04-29T22:47:57.000Z","date":"2022-04-27","kind":"tax_withholding","acquired":false,"shares":184,"price":249.87,"value":45976.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 4,363 RSUs which will vest on 11/2/2022; 3,023 RSUs which will vest in installments of 1,489 on 5/3/2022 and 1,534 on 5/3/2023; 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024; and 4,006 RSUs which vest in\ninstallments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,105 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":47755,"source":{"system":"sec-edgar","filing":"0001127602-22-012766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222012766/form4.xml","form_type":"4"}},{"id":68314,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2022-03-22T21:47:57.000Z","date":"2022-03-18","kind":"tax_withholding","acquired":false,"shares":4995,"price":235.86,"value":1178120.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 345 RSUs which will vest on 4/27/2022; 4,363 RSUs which will vest on 11/2/2022; 3,023 RSUs which will vest in installments of 1,489 on 5/3/2022 and 1,534 on 5/3/2023; 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024; and 4,006 RSUs which vest in\ninstallments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,148 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":47939,"source":{"system":"sec-edgar","filing":"0001127602-22-010198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222010198/form4.xml","form_type":"4"}},{"id":69575,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2022-03-04T00:33:41.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":9989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 345 RSUs which will vest on 4/27/2022; 4,363 RSUs which will vest on 11/2/2022; 3,023 RSUs which will vest in installments of 1,489 on 5/3/2022 and 1,534 on 5/3/2023; 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024; and 4,006 RSUs which vest in\ninstallments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,012 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":52714,"source":{"system":"sec-edgar","filing":"0001127602-22-008139","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222008139/form4.xml","form_type":"4"}},{"id":77765,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-11-03T23:27:34.000Z","date":"2021-11-02","kind":"tax_withholding","acquired":false,"shares":2192,"price":209.74,"value":459750.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units granted under the Company's equity plans: 345 RSUs which will vest on 4/27/2022; 4,363 RSUs which vest on 11/2/2022; 3,023 RSUs which will vest in installments of 1,489 on 5/3/2022 and 1,534 on 5/3/2023; 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024; and 4,006 RSUs which vest in installments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 880 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42593,"source":{"system":"sec-edgar","filing":"0001127602-21-028367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221028367/form4.xml","form_type":"4"}},{"id":88884,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2021-05-04T23:41:15.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":34782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively."}],"balance_after":34782,"derivative":{"exercise_price":239.64,"exercise_date":"2023-04-30","expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":34782},"source":{"system":"sec-edgar","filing":"0001127602-21-015366","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015366/form4.xml","form_type":"4"}},{"id":88883,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-05-04T23:41:15.000Z","date":"2021-05-03","kind":"tax_withholding","acquired":false,"shares":745,"price":239.64,"value":178531.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 345 RSUs which will vest on 4/27/2022; 8,597 RSUs which vest in installments of 4,234 on 11/2/2021 and 4,363 on 11/2/2022; 3,023 RSUs which will vest in installments of 1,489 on 5/3/2022 and 1,534 on 5/3/2023; 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024; and 4,006 RSUs which vest in\ninstallments of 1,321 on 4/30/2023, 1,322 on 4/30/2024 and 1,363 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 953 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":44472,"source":{"system":"sec-edgar","filing":"0001127602-21-015366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015366/form4.xml","form_type":"4"}},{"id":88882,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-05-04T23:41:15.000Z","date":"2021-05-01","kind":"tax_withholding","acquired":false,"shares":1109,"price":239.64,"value":265760.76,"ownership":{"direct":true},"balance_after":45217,"source":{"system":"sec-edgar","filing":"0001127602-21-015366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015366/form4.xml","form_type":"4"}},{"id":88881,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-05-04T23:41:15.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":4006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively."}],"balance_after":46326,"source":{"system":"sec-edgar","filing":"0001127602-21-015366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015366/form4.xml","form_type":"4"}},{"id":89160,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-04-29T00:17:23.000Z","date":"2021-04-27","kind":"tax_withholding","acquired":false,"shares":174,"price":255.52,"value":44460.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,673 RSUs which will vest on 5/1/2021; 335 RSUs which will vest on 5/1/2021; 345 RSUs which will vest on 4/27/2022; 8,597 RSUs which vest in installments of 4,234 on 11/2/2021 and 4,363 on 11/2/2022; 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023; and 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,280 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42320,"source":{"system":"sec-edgar","filing":"0001127602-21-014607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221014607/form4.xml","form_type":"4"}},{"id":90723,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-03-22T22:34:57.000Z","date":"2021-03-19","kind":"tax_withholding","acquired":false,"shares":1401,"price":244.42,"value":342432.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,673 RSUs which vest on 5/1/2021; 335 RSUs which vest on 5/1/2021; 680 RSUs which vest in installments of 335 on 4/27/2021 and 345 on 4/27/2022; 8,597 RSUs which vest in installments of 4,234 on 11/2/2021 and 4,363 on 11/2/2022; 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023; and 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,310 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42494,"source":{"system":"sec-edgar","filing":"0001127602-21-011715","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221011715/form4.xml","form_type":"4"}},{"id":91654,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-03-05T01:35:54.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":2803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,673 RSUs which vest on 5/1/2021; 335 RSUs which vest on 5/1/2021; 680 RSUs which vest in installments of 335 on 4/27/2021 and 345 on 4/27/2022; 8,597 RSUs which vest in installments of 4,234 on 11/2/2021 and 4,363 on 11/2/2022; 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023; and 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,152 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":43715,"source":{"system":"sec-edgar","filing":"0001127602-21-009483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221009483/form4.xml","form_type":"4"}},{"id":93389,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2021-02-17T01:59:21.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":54.69,"exercise_date":"2013-04-25","expiration_date":"2021-04-25","underlying":"Common Stock","underlying_shares":2300},"source":{"system":"sec-edgar","filing":"0001127602-21-006060","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221006060/form4.xml","form_type":"4"}},{"id":93388,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-02-17T01:59:21.000Z","date":"2021-02-16","kind":"tax_withholding","acquired":false,"shares":1147,"price":237.21,"value":272079.87,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Non-market exercise of 2,300 stock options expiring April 25, 2021 wherein 1,147 shares issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and tax withholding, with the remaining shares delivered to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,673 RSUs which vest on 5/1/2021; 335 RSUs which vest on 5/1/2021; 680 RSUs which vest in installments of 335 on 4/27/2021 and 345 on 4/27/2022; 8,597 RSUs which vest in installments of 4,234 on 11/2/2021 and 4,363 on 11/2/2022; 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023; and 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 1,152 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":40912,"source":{"system":"sec-edgar","filing":"0001127602-21-006060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221006060/form4.xml","form_type":"4"}},{"id":93387,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-02-17T01:59:21.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":2300,"price":54.69,"value":125787.0,"ownership":{"direct":true},"balance_after":42059,"source":{"system":"sec-edgar","filing":"0001127602-21-006060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221006060/form4.xml","form_type":"4"}},{"id":99222,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-11-05T00:06:46.000Z","date":"2020-11-02","kind":"tax_withholding","acquired":false,"shares":2125,"price":216.94,"value":460997.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,673 RSUs which vest on 5/1/2021; 335 RSUs which vest on 5/1/2021; 680 RSUs which vest in installments of 335 on 4/27/2021 and 345 on 4/27/2022; 8,597 RSUs which vest in installments of 4,234 on 11/2/2021 and 4,363 on 11/2/2022; 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023; and 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,012 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":39619,"source":{"system":"sec-edgar","filing":"0001127602-20-028206","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220028206/form4.xml","form_type":"4"}},{"id":104954,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2020-05-08T01:04:52.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":29050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively."}],"balance_after":29050,"derivative":{"exercise_price":236.36,"exercise_date":"2022-05-05","expiration_date":"2030-05-05","underlying":"Common Stock","underlying_shares":29050},"source":{"system":"sec-edgar","filing":"0001127602-20-015865","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015865/form4.xml","form_type":"4"}},{"id":104953,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-05-08T01:04:52.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":3469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 1,673 RSUs which vest on 5/1/2021; 335 RSUs which vest on 5/1/2021; 680 RSUs which vest in installments of 335 on 4/27/2021 and 345 on 4/27/2022; 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022; 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023; and 3,469 RSUs which vest in installments of 1,144 on 5/5/2022, 1,145 on 5/5/2023 and 1,180 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 926 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":41408,"source":{"system":"sec-edgar","filing":"0001127602-20-015865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015865/form4.xml","form_type":"4"}},{"id":105060,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-05-05T23:57:48.000Z","date":"2020-05-03","kind":"tax_withholding","acquired":false,"shares":185,"price":230.98,"value":42731.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,673 RSUs which vest on 5/1/2021; 335 RSUs which vest on 5/1/2021; 680 RSUs which vest in installments of 335 on 4/27/2021 and 345 on 4/27/2022; 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022; and 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 926 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":37939,"source":{"system":"sec-edgar","filing":"0001127602-20-015556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015556/form4.xml","form_type":"4"}},{"id":105059,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-05-05T23:57:48.000Z","date":"2020-05-01","kind":"tax_withholding","acquired":false,"shares":1046,"price":239.22,"value":250224.12,"ownership":{"direct":true},"balance_after":38124,"source":{"system":"sec-edgar","filing":"0001127602-20-015556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015556/form4.xml","form_type":"4"}},{"id":105258,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-04-29T23:04:25.000Z","date":"2020-04-27","kind":"tax_withholding","acquired":false,"shares":168,"price":236.28,"value":39695.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 348 RSUs which vest on 5/3/2020; 3,297 RSUs which vest in installments of 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 680 RSUs which vest in installments of 335 on 4/27/2021 and 345 on 4/27/2022; 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022; and 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,138 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":39170,"source":{"system":"sec-edgar","filing":"0001127602-20-014704","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220014704/form4.xml","form_type":"4"}},{"id":105966,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-03-24T22:09:27.000Z","date":"2020-03-20","kind":"tax_withholding","acquired":false,"shares":1855,"price":198.76,"value":368699.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 348 RSUs which vest on 5/3/2020; 3,297 RSUs which vest in installments of 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 1,014 RSUs which vest in installments of 334 on 4/27/2020, 335 on 4/27/2021 and 345 on 4/27/2022; 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022; and 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,157 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":39338,"source":{"system":"sec-edgar","filing":"0001127602-20-011873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220011873/form4.xml","form_type":"4"}},{"id":106292,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2020-03-11T01:12:01.000Z","date":"2020-03-09","kind":"exercise","acquired":true,"shares":1480,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":58.43,"exercise_date":"2012-04-26","expiration_date":"2020-04-26","underlying":"Common Stock","underlying_shares":1480},"source":{"system":"sec-edgar","filing":"0001127602-20-010170","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220010170/form4.xml","form_type":"4"}},{"id":106291,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-03-11T01:12:01.000Z","date":"2020-03-09","kind":"tax_withholding","acquired":false,"shares":780,"price":210.65,"value":164307.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Non-market exercise of 1,480 stock options expiring April 26, 2020 wherein 780 shares issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and tax withholding, with the remaining shares delivered to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 348 RSUs which vest on 5/3/2020; 3,297 RSUs which vest in installments of 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 1,014 RSUs which vest in installments of 334 on 4/27/2020, 335 on 4/27/2021 and 345 on 4/27/2022; 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022; and 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 978 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":40985,"source":{"system":"sec-edgar","filing":"0001127602-20-010170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220010170/form4.xml","form_type":"4"}},{"id":106290,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-03-11T01:12:01.000Z","date":"2020-03-09","kind":"exercise","acquired":false,"shares":1480,"price":58.43,"value":86476.4,"ownership":{"direct":true},"balance_after":41765,"source":{"system":"sec-edgar","filing":"0001127602-20-010170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220010170/form4.xml","form_type":"4"}},{"id":106397,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-03-06T00:58:02.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":3711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 348 RSUs which vest on 5/3/2020; 3,297 RSUs which vest in installments of 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 1,014 RSUs which vest in installments of 334 on 4/27/2020, 335 on 4/27/2021 and 345 on 4/27/2022; 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022; and 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 978 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":40285,"source":{"system":"sec-edgar","filing":"0001127602-20-009712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220009712/form4.xml","form_type":"4"}},{"id":116881,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2019-05-07T23:06:01.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":39382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options are exercisable in three annual installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively."}],"balance_after":39382,"derivative":{"exercise_price":177.31,"exercise_date":"2021-05-03","expiration_date":"2029-05-03","underlying":"Common Stock","underlying_shares":39382},"source":{"system":"sec-edgar","filing":"0001127602-19-017653","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017653/form4.xml","form_type":"4"}},{"id":116880,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2019-05-07T23:06:01.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":4511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 348 RSUs which vest on 5/3/2020; 3,297 RSUs which vest in installments of 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 1,014 RSUs which vest in installments of 334 on 4/27/2020, 335 on 4/27/2021 and 345 on 4/27/2022; 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022; and 4,511 RSUs which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 479 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":36075,"source":{"system":"sec-edgar","filing":"0001127602-19-017653","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017653/form4.xml","form_type":"4"}},{"id":116879,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2019-05-07T23:06:01.000Z","date":"2019-05-03","kind":"tax_withholding","acquired":false,"shares":174,"price":176.5,"value":30711.0,"ownership":{"direct":true},"balance_after":31564,"source":{"system":"sec-edgar","filing":"0001127602-19-017653","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017653/form4.xml","form_type":"4"}},{"id":117035,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2019-05-03T21:54:22.000Z","date":"2019-05-01","kind":"tax_withholding","acquired":false,"shares":851,"price":179.3232,"value":152604.0432,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 686 RSUs which vest in installments of 338 on 5/3/2019 and 348 on 5/3/2020; 3,297 RSUs which vest in installments of 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 1,014 RSUs which vest in installments of 334 on 4/27/2020, 335 on 4/27/2021 and 345 on 4/27/2022; and 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 507 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":31738,"source":{"system":"sec-edgar","filing":"0001127602-19-017349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017349/form4.xml","form_type":"4"}},{"id":117034,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2019-05-03T21:54:22.000Z","date":"2019-05-01","kind":"tax_withholding","acquired":false,"shares":163,"price":179.3232,"value":29229.6816,"ownership":{"direct":true},"balance_after":32859,"source":{"system":"sec-edgar","filing":"0001127602-19-017349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017349/form4.xml","form_type":"4"}},{"id":118124,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2019-03-25T23:41:51.000Z","date":"2019-03-22","kind":"tax_withholding","acquired":false,"shares":1769,"price":191.89,"value":339453.41,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 686 RSUs which vest in installments of 338 on 5/3/2019 and 348 on 5/3/2020; 4,920 RSUs which vest in installments of 1,623 on 5/1/2019, 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021; 1,014 RSUs which vest in installments of 334 on 4/27/2020, 335 on 4/27/2021 and 345 on 4/27/2022; and 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 617 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":32752,"source":{"system":"sec-edgar","filing":"0001127602-19-013166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219013166/form4.xml","form_type":"4"}},{"id":118671,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2019-03-09T00:44:38.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":3676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 686 RSUs which vest in installments of 338 on 5/3/2019 and 348 on 5/3/2020; 4,920 RSUs which vest in installments of 1,623 on 5/1/2019, 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021; 1,014 RSUs which vest in installments of 334 on 4/27/2020, 335 on 4/27/2021 and 345 on 4/27/2022; and 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 450 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":34324,"source":{"system":"sec-edgar","filing":"0001127602-19-010659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219010659/form4.xml","form_type":"4"}},{"id":120684,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2019-02-01T23:25:29.000Z","date":"2019-01-30","kind":"tax_withholding","acquired":false,"shares":115,"price":192.11,"value":22092.65,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 686 RSUs which vest in installments of 338 on 5/3/2019 and 348 on 5/3/2020; 4,920 RSUs which vest in installments of 1,623 on 5/1/2019, 1,624 on 5/1/2020 and 1,673 on 5/1/2021; 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021; 1,014 RSUs which vest in installments of 334 on 4/27/2020, 335 on 4/27/2021 and 345 on 4/27/2022; and 12,830 RSUs which vest in installments of 4,233 on 11/2/2020 4,234 on 11/2/2021 and 4,363 on 11/2/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 450 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":30648,"source":{"system":"sec-edgar","filing":"0001127602-19-003515","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219003515/form4.xml","form_type":"4"}},{"id":123211,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2018-11-06T23:20:22.000Z","date":"2018-11-02","kind":"grant","acquired":true,"shares":12830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 11/2/2020, 11/2/2021 and 11/2/2022, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 313 RSUs which vest fully in one installment on 1/30/2019; 686 RSUs which vest in installments of 338 and 348 on 5/3/2019 and 5/3/2020, respectively; 4,920 RSUs which vest in installments of 1,623, 1,624 and 1,673 on 5/1/2019, 5/1/2020 and 5/1/2021, respectively; 984 RSUs which vest in installments of 324, 325 and 335 on 5/1/2019, 5/1/2020 and 5/1/2021, respectively; 1,014 RSUs which vest in installments of 334, 335 and 345 on 4/27/2020, 4/27/2021 and 4/27/2022, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 338 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":30618,"source":{"system":"sec-edgar","filing":"0001127602-18-032310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218032310/form4.xml","form_type":"4"}}]}